Skip to main navigation
Aveo Oncology
  • Home
  • Contact Us
  • About AVEO
    • The Human Response
    • Management Team
    • Board of Directors
    • Partnerships
  • Our Product Candidates
    • Overview
    • Tivozanib
    • Ficlatuzumab
    • AV-203
    • AV-380
  • Publications & Presentations
  • For Media
  • For Investors
  • Join Our Team

For Investors

  • Investor Home
  • Corporate Governance
  • Stock Information
  • Research Coverage
  • SEC Filings
  • Annual Reports
  • Press Releases
  • Scientific Publications & Presentations
  • Calendar of Events
  • FAQs
  • Information Request

Tools

  • Print Page
  • RSS Feeds
  • E-mail Alerts
  • IR Contacts

IR Contacts

IR Contacts

AVEO Oncology
Investor Relations
Phone: 617-588-1960
E-mail: ir@aveooncology.com

© 2018 AVEO Pharmaceuticals, Inc. All rights reserved.

  • Linkedin
  • Twitter
  • Youtube

Contact Us  |  Site Map  |  Terms of Use  |  Privacy Policy